Rossari Biotech balance sheet

As of Sep 2026

Total assets: ₹2,359cr+13.0% on Sep 2025
Shareholders' equity: ₹1,408cr+12.5% on Sep 2025
Total debt: ₹362cr+11.7% on Sep 2025
Cash and investments: ₹114cr+106.2% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	511	561	354	315	314
	156	173	140	47.2	13.1
	119	119	119	119	119
	187	105	126	144	151
	—	—	—	0.0	3.0
	27.9	27.0	26.3	25.1	25.0
	0.0	0.2	0.2	0.2	0.2
	9.7	8.8	7.4	3.4	3.5
	9.7	9.1	7.6	3.6	3.7
	17.2	14.9	10.5	4.8	3.2
	30.8	36.4	70.1	69.1	14.8
	1,059	1,045	853	727	646
	444	405	355	282	188
	30.0	35.1	57.3	37.6	26.0
	554	557	475	425	354
	84.4	75.3	44.2	25.2	69.8
	26.4	16.9	13.0	5.0	54.7
	1.0	1.2	1.2	0.7	0.3
	6.4	5.9	3.2	4.6	1.2
	702	692	593	498	506
	155	140	93.4	63.0	26.9
	1,301	1,236	1,042	844	721
	7.8	7.8	1.2	1.2	—
	2,359	2,289	1,896	1,572	1,368
Equity
	11.1	11.1	11.1	11.0	11.0
	1,397	1,322	1,174	1,037	904
	1,408	1,333	1,185	1,048	915
	1,408	1,333	1,185	1,048	915
Liabilities
	82.1	94.3	100	33.3	34.9
	17.2	20.3	22.3	10.9	7.4
	99.3	115	122	44.2	42.3
	9.5	8.3	5.3	4.0	4.5
	40.2	43.0	46.6	51.5	58.7
	149	166	174	99.7	106
	280	314	87.9	72.5	39.0
	344	323	286	219	185
	133	124	123	103	106
	756	761	497	394	330
	8.8	8.3	7.3	4.5	1.7
	11.8	9.0	12.2	10.1	8.5
	26.0	11.4	20.1	15.8	6.4
	803	790	537	425	347
	952	955	711	524	452
	2,359	2,289	1,896	1,572	1,368
Trade payables — MSME split
	30.3	35.9	23.5	—	—
	313	288	263	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ROSSARI₹415.00

Rossari Biotech Limited

· Chemicals

₹ CrorePeersNOCIL HSCL NAVINFLUOR DDEVPLSTIK CHEMPLASTS TATACHEM AARTIIND JGCHEMMcap ₹2,298 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	313.6	314.7	353.5	560.5	510.7
+ Capital Work-in-Progress	13.1	47.2	140.2	173.3	156.2
+ Goodwill	118.7	118.7	118.7	118.7	118.7
+ Other Intangibles	151.3	144.2	126.1	105.2	187.5
+ Intangibles under Development	3.0	0.0	—	—	—
+ Investments (Equity Method)	25.0	25.1	26.3	27.0	27.9
+ Non-current Investments	0.2	0.2	0.2	0.2	0.0
+ Other Non-current Financial Assets	3.5	3.4	7.4	8.8	9.7
Non-current Financial Assets	3.7	3.6	7.6	9.1	9.7
+ Deferred Tax Assets	3.2	4.8	10.5	14.9	17.2
+ Other Non-current Assets	14.8	69.1	70.1	36.4	30.8
Total Non-current Assets	646.4	727.4	853.0	1,045.1	1,058.8
Current Assets
+ Inventories	188.5	282.3	355.1	404.5	444.0
+ Current Investments	26.0	37.6	57.3	35.1	30.0
+ Trade Receivables	353.7	425.1	474.5	557.4	553.7
+ Cash & Cash Equivalents	69.8	25.2	44.2	75.3	84.4
+ Other Bank Balances	54.7	5.0	13.0	16.9	26.4
+ Short-term Loans	0.3	0.7	1.2	1.2	1.0
+ Other Current Financial Assets	1.2	4.6	3.2	5.9	6.4
Current Financial Assets	505.7	498.2	593.5	691.8	701.9
+ Other Current Assets	26.9	63.0	93.4	139.6	154.7
Total Current Assets	721.2	843.6	1,041.9	1,235.9	1,300.7
+ Assets Held for Sale	—	1.2	1.2	7.8	7.8
Total Assets	1,367.6	1,572.2	1,896.2	2,288.8	2,359.5
Equity
+ Equity Share Capital	11.0	11.0	11.1	11.1	11.1
+ Other Equity / Reserves	904.1	1,036.7	1,174.4	1,322.3	1,396.5
Equity — Owners of Parent	915.2	1,047.7	1,185.4	1,333.3	1,407.6
Total Equity	915.2	1,047.7	1,185.4	1,333.3	1,407.6
Liabilities
+ Borrowings — Non-current	34.9	33.3	100.0	94.3	82.1
+ Other Non-current Financial Liab	7.4	10.9	22.3	20.3	17.2
Non-current Financial Liabilities	42.3	44.2	122.3	114.6	99.3
+ Provisions — Non-current	4.5	4.0	5.3	8.3	9.5
+ Deferred Tax Liabilities	58.7	51.5	46.6	43.0	40.2
Non-current Liabilities	105.5	99.7	174.2	165.9	149.0
+ Borrowings — Current	39.0	72.5	87.9	313.7	279.7
+ Trade Payables	185.2	219.1	286.3	323.5	343.6
+ Other Current Financial Liab	106.1	102.7	122.6	123.7	133.0
Current Financial Liabilities	330.3	394.3	496.9	760.8	756.2
+ Provisions — Current	1.7	4.5	7.3	8.3	8.8
+ Current Tax Liabilities	8.5	10.1	12.2	9.0	11.8
+ Other Current Liabilities	6.4	15.8	20.1	11.4	26.0
Current Liabilities	346.9	424.7	536.6	789.6	802.9
Total Liabilities	452.4	524.4	710.7	955.4	951.9
Total Equity & Liabilities	1,367.6	1,572.2	1,896.2	2,288.8	2,359.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	23.5	35.9	30.3
+ Dues to Other Creditors — Current	—	—	262.8	287.6	313.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.